Cytotoxicity of Vibrio vulnificus cytolysin on rat peritoneal mast cells.
Histamine has been thought to be a permeability enhancing factor in Vibrio vulnificus infection. The injection of living bacteria or purified V. vulnificus cytolysin (VVC) can cause lethality in mice by inducing hemoconcentration and increased vascular permeability. In the present study, we tried to identify whether histamine release causes the increased vascular permeability that is responsible for the lethal effect of VVC. Treatment of rat peritoneal mast cells with high concentrations of VVC caused the release of whole cellular histamine and lactate dehydrogenase (LDH). At concentrations less than 10 HU/ml, histamine and LDH were not released whereas preloaded 2-deoxy-D-glucose was rapidly effluxed with the concomitant decrease in cellular ATP. VVC-treated mast cells were refractory to the stimulation of histamine secretion by Compound 48/80 but remained fully responsive to Ca2+ plus GTP-gamma-S. These results indicate that histamine can be released from mast cells only when the concentration of VVC is high enough to cause the lysis of cells. At low concentrations, VVC does not induce the release of stored histamine from damaged cells. The intravenous injection of 80 HU purified VVC to rats, which can produce the calculated blood concentration of about 3 HU/ml, caused a marked increase in pulmonary vascular permeability, hemoconcentration and death. However, no increase in blood histamine level was detected. This level of VVC in rat blood was enough to cause severe hemoconcentration and lethality but might not be enough to cause cytolysis of the mast cells and resulting histamine release.
Department of Biochemistry, Chonbuk National University Medical School and Institutes for Medical Sciences, Chonju, Republic of Korea.
J S
JS
Kim
M R
MR
Chae
K
K
Chang
K H
KH
Park
H W
HW
Rho
B H
BH
Park
J W
JW
Park
H R
HR
Kim
D000818:Animals; D002118:Calcium / Q000378:metabolism; D003603:Cytotoxins / Q000008:administration & dosage / Q000378:metabolism* / Q000633:toxicity; D005260:Female; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000378:metabolism; D006636:Histamine Release; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism*; D010537:Peritoneum / Q000166:cytology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014733:Vibrio; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D003603:Cytotoxins; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D003189:p-Methoxy-N-methylphenethylamine; D007770:L-Lactate Dehydrogenase; D002118:Calcium